Effects of the Immunosuppressive Drugs CsA and FK506 on Intracellular Signalling and Gene Regulation
- 1 December 1997
- journal article
- review article
- Published by Elsevier in Immunobiology
- Vol. 198 (1-3) , 192-206
- https://doi.org/10.1016/s0171-2985(97)80040-x
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycinInternational Immunology, 1995
- Identification of Soluble Protein Phosphatases That Dephosphorylate Voltage-sensitive Sodium Channels in Rat BrainJournal of Biological Chemistry, 1995
- A Putative Sirolimus (Rapamycin) Effector ProteinBiochemical and Biophysical Research Communications, 1994
- Interleukin-8 is a Cyclosporin A binding proteinCellular and Molecular Life Sciences, 1993
- Expression of PILOT, a putative transcription factor, requires two signals and is cyclosporin A sensitive in T cellsInternational Immunology, 1993
- cDNA Cloning of a human 5 kDa FK506 and rapamycin binding proteinBiochemical and Biophysical Research Communications, 1992
- Unexpected up-regulation of gene expression by cyclosporin A and FK-506 in a T-cell lymphoma: Both immunosuppressants augment Ly-6E antigen induction by interferon-γ in the presence of ionomycinInternational Journal of Immunopharmacology, 1991
- Induction of members of the IL-8/NAP-1 gene family in human T lymphocytes is suppressed by cyclosporin ABiochemical and Biophysical Research Communications, 1991
- FK-506 enters the clinicImmunology Today, 1990
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989